epigallocatechin gallate has been researched along with Burns in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butt, H; Ejaz, A; Humayun, S; Mehmood, A; Riazuddin, S | 1 |
| Faezizadeh, Z; Gharib, A; Godarzee, M | 1 |
2 other study(ies) available for epigallocatechin gallate and Burns
| Article | Year |
|---|---|
Epigallocatechin-3-gallate protects Wharton's jelly derived mesenchymal stem cells against in vitro heat stress.
Topics: Burns; Catechin; Cells, Cultured; Hot Temperature; Humans; MAP Kinase Signaling System; Mesenchymal Stem Cells; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Wharton Jelly | 2020 |
Therapeutic efficacy of epigallocatechin gallate-loaded nanoliposomes against burn wound infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Burns; Catechin; Kidney; Liposomes; Liver; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Nanostructures; Skin; Spleen; Staphylococcal Infections; Wound Infection | 2013 |